Your browser is no longer supported. Please, upgrade your browser.
EVFM Evofem Biosciences, Inc. daily Stock Chart
Evofem Biosciences, Inc.
Index- P/E- EPS (ttm)-1.91 Insider Own2.80% Shs Outstand48.20M Perf Week1.40%
Market Cap323.13M Forward P/E- EPS next Y-1.13 Insider Trans-3.54% Shs Float61.43M Perf Month6.75%
Income-81.10M PEG- EPS next Q-0.35 Inst Own59.30% Short Float4.19% Perf Quarter-16.91%
Sales- P/S- EPS this Y65.40% Inst Trans23.18% Short Ratio3.36 Perf Half Y-16.91%
Book/sh0.02 P/B253.00 EPS next Y2.00% ROA-236.20% Target Price- Perf Year-21.31%
Cash/sh0.16 P/C31.07 EPS next 5Y73.50% ROE-424.00% 52W Range3.34 - 7.50 Perf YTD-17.99%
Dividend- P/FCF- EPS past 5Y42.70% ROI- 52W High-32.53% Beta0.34
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low51.50% ATR0.51
Employees53 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)47.31 Volatility12.84% 9.59%
OptionableYes Debt/Eq0.00 EPS Q/Q40.90% Profit Margin- Rel Volume1.55 Prev Close5.46
ShortableYes LT Debt/Eq0.00 EarningsMay 06 BMO Payout- Avg Volume766.71K Price5.06
Recom1.70 SMA20-2.20% SMA50-0.27% SMA200-5.93% Volume1,188,346 Change-7.33%
Oct-16-19Resumed Cantor Fitzgerald Overweight $9
May-31-20 05:15PM  
May-28-20 06:30AM  
May-27-20 10:56AM  
May-26-20 10:32AM  
May-22-20 04:37PM  
May-21-20 04:05PM  
May-18-20 04:05PM  
May-13-20 08:00AM  
May-08-20 09:00AM  
May-07-20 07:30AM  
May-06-20 10:44PM  
May-01-20 05:21PM  
Apr-28-20 08:00AM  
Apr-24-20 08:30AM  
Apr-19-20 07:02AM  
Apr-10-20 04:05PM  
Mar-30-20 05:14PM  
Mar-27-20 08:30AM  
Mar-25-20 05:00PM  
Mar-24-20 04:00PM  
Mar-19-20 08:15AM  
Mar-12-20 09:00AM  
Mar-09-20 11:53AM  
Feb-26-20 08:30AM  
Feb-16-20 08:25AM  
Dec-22-19 05:32PM  
Dec-18-19 07:30AM  
Dec-03-19 09:00AM  
Dec-02-19 08:07AM  
Nov-24-19 04:19PM  
Nov-19-19 03:32PM  
Nov-14-19 08:00AM  
Nov-13-19 04:05PM  
Nov-08-19 08:30PM  
Nov-07-19 11:26AM  
Nov-06-19 04:05PM  
Oct-24-19 09:00AM  
Sep-25-19 09:00AM  
Sep-11-19 01:31PM  
Aug-26-19 06:00AM  
Aug-22-19 09:30AM  
Aug-08-19 11:23AM  
Aug-07-19 08:24PM  
Aug-05-19 04:10PM  
Jul-30-19 09:00AM  
Jul-01-19 09:31AM  
Jun-10-19 04:01PM  
May-30-19 11:02AM  
May-14-19 09:00AM  
May-10-19 10:51AM  
May-09-19 07:24PM  
May-07-19 06:00AM  
Apr-30-19 09:00AM  
Apr-23-19 08:11AM  
Apr-16-19 08:30AM  
Apr-11-19 10:25AM  
Apr-03-19 09:00AM  
Mar-12-19 09:00AM  
Mar-03-19 11:00PM  
Mar-01-19 06:00AM  
Feb-19-19 09:00AM  
Jan-07-19 07:20AM  
Jan-03-19 08:00AM  
Dec-20-18 10:13AM  
Dec-19-18 09:17AM  
Dec-18-18 02:01PM  
Dec-17-18 01:30PM  
Nov-15-18 06:50AM  
Nov-08-18 06:50AM  
Nov-07-18 06:50AM  
Nov-01-18 08:00AM  
Oct-24-18 08:30AM  
Oct-09-18 02:21PM  
Sep-26-18 08:00AM  
Sep-21-18 08:00AM  
Sep-18-18 08:00AM  
Sep-11-18 10:24AM  
Aug-29-18 09:00AM  
Aug-23-18 09:00AM  
Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora, a non-hormonal woman-controlled vaginal gel, which is in Phase 3 clinical trial for the prevention of pregnancy; and in Phase 2b trial for the prevention of chlamydia and gonorrhea in women. The company is also developing multi-purpose vaginal pH regulator gel product candidate for the reduction of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Culwell KellyChief Medical OfficerMay 01Sale4.751,0004,750194,226May 01 08:12 PM
Culwell KellyChief Medical OfficerApr 30Sale4.661,0004,660195,226May 01 08:12 PM
Lynch Thomas GDirectorMar 31Option Exercise0.0037,5000325,000Apr 01 04:11 PM
Barrans RussellChief Commercial OfficerFeb 19Sale6.5014,95797,221332,240Feb 21 02:10 PM
Culwell KellyChief Medical OfficerFeb 19Sale7.001,0007,000196,226Feb 21 02:10 PM
Barrans RussellChief Commercial OfficerJan 16Sale6.501,57810,257196,298Jan 21 01:13 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 13Sale6.003,29519,770362,289Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 13Sale6.001,6489,888177,251Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 02Sale6.053,35220,280178,899Jan 06 03:07 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 02Sale6.056,70540,565365,584Jan 06 03:08 PM
Lynch Thomas GDirectorDec 31Option Exercise0.0037,5000287,500Dec 31 08:48 PM
Culwell KellyChief Medical OfficerDec 02Sale7.351,0007,35043,538Dec 04 05:34 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 02Sale7.3020,000146,000372,289Dec 04 05:33 PM
File Justin J.Chief Financial OfficerDec 02Sale7.1610,00071,600182,251Dec 04 05:33 PM
PELLETIER SAUNDRA LChief Executive OfficerNov 21Sale6.0110,00060,100414,676Nov 21 08:18 PM
File Justin J.Chief Financial OfficerNov 21Sale6.004,90029,400202,353Nov 21 08:18 PM
File Justin J.Chief Financial OfficerNov 20Sale6.00100600207,253Nov 21 08:18 PM